Acupuncture Clinical Trial
Official title:
The Safety and Efficacy of Acupuncture in Moderate to Severe Cyclic Breast Pain
This study is conducted to assess the efficacy and safety of acupuncture in moderate to severe cyclic breast pain.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | September 30, 2024 |
Est. primary completion date | March 31, 2024 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 55 Years |
Eligibility | Inclusion Criteria: - Meeting the diagnosis criteria of cyclic breast pain. - Female patients aged between 18 and 55. - Relatively regular menstrual cycle. - Cyclic breast pain lasting for 3 consecutive menstrual cycles or more. - The score of worst pain =5 on Numerical Rating Scale and any level of breast pain lasting 5-21 days during the run-in period of one menstrual cycle. - No previous experience of acupuncture for breast diseases. - Willing to use nonhormonal contraceptives if any risk of pregnancy. - Volunteer to the trial and signing written informed consent. Exclusion Criteria: - Noncyclic breast pain. - Extramammary pain only. - A history of breast cancer or suspicious of malignancy breast disease by examinations. - The Breast Imaging Reporting and Data System (BI-RADS) category 4-6 in ultrasound or mammography examinations. - Combined with mastitis. - Breast pain following injury, surgery, hormones, and/or other drugs. - Usage of hormones (including hormonal contraceptives) in the past three months. - Combined with severe diseases in the cardiac, respiratory, renal, liver, and hematopoietic systems, psychiatric disorder and/or cognitive disorders. - A history of bilateral ovariectomy or premature ovarian failure. - Pregnancy, lactation, or wishing to conceive before the end of the trial. - Poor adherence. |
Country | Name | City | State |
---|---|---|---|
China | Yuanjie Sun | Beijing | Beijing |
Lead Sponsor | Collaborator |
---|---|
Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Expectance assessment | Patients will be asked what do you think the condition of breast pain will be in three menstrual cycles. | At the end of Cycle 0 (each cycle is 25-35 days) | |
Other | Assessment of belief in acupuncture | Patients will be asked do you think acupuncture can help to treat your breast pain. | At the end of the Cycle 0 and Cycle 3 (each cycle is 25-35 days) | |
Other | Blinding assessment | Participants will be ask do you think you have received traditional acupuncture in the past 3 menstrual cycles. | Within 5 minutes after the last treatment | |
Other | Adherence assessment | Adherence will be assessed via counting treatment sessions. Those complete over 80% treatment sessions will be defined as of good adherence. | Through the Cycle 1, cycle 2, and cycle 3 (each cycle is 25-35 days) | |
Other | Proportion of participants using rescue medicine. | Through study completion, an average of one and a half years. | ||
Other | Proportion of participants using concomitant medicine or therapy that might impact breast pain. | Through study completion, an average of one and a half years. | ||
Primary | The change from baseline in the numerical rating scale (NRS) score on the worst breast pain. | Participants will fill in the Cardiff Breast Pain Chart to assess the intensity of worst and average pain daily in the form of NRS score ranging from 0-10. 0 refers to no pain and 10 refers to the worst pain imaginable. The highest NRS score on the worst breast pain during the cycle is defined as the final score on the worst pain. | Through the Cycle 3 (each cycle is 25-35 days) | |
Secondary | The change from baseline in the numerical rating scale (NRS) score on the worst breast pain. | Participants will fill in the Cardiff Breast Pain Chart to assess the intensity of worst and average pain daily in the form of NRS score ranging from 0-10. 0 refers to no pain and 10 refers to the worst pain imaginable. The highest NRS score on the worst breast pain during the cycle is defined as the final score on the worst pain. | Through the Cycle 1, Cycle 2, Cycle 6 and Cycle 9 (each cycle is 25-35 days) | |
Secondary | The change from baseline in the numerical rating scale (NRS) score on the average breast pain. | Participants will fill in the Cardiff Breast Pain Chart to assess the intensity of worst and average pain daily in the form of NRS score ranging from 0-10. 0 refers to no pain and 10 refers to the worst pain imaginable. The average NRS score on the average breast pain during the cycle is defined as the mean of the average pain score during the cycle. | Through the Cycle 1, Cycle 2, Cycle 3, Cycle 6 and Cycle 9 (each cycle is 25-35 days) | |
Secondary | Proportion of participants with at least 50% reduction of NRS score on the worst breast pain. | Participants will fill in the Cardiff Breast Pain Chart to assess the intensity of worst and average pain daily in the form of NRS score ranging from 0-10. 0 refers to no pain and 10 refers to the worst pain imaginable. The highest NRS score on the worst breast pain during the cycle is defined as the final score on the worst pain. | Through the Cycle 1, Cycle 2, Cycle 3, Cycle 6 and Cycle 9 (each cycle is 25-35 days) | |
Secondary | Proportion of participants with at least 50% reduction of NRS score on the average breast pain. | Participants will fill in the Cardiff Breast Pain Chart to assess the intensity of worst and average pain daily in the form of NRS score ranging from 0-10. 0 refers to no pain and 10 refers to the worst pain imaginable. The average NRS score on the average breast pain during the cycle is defined as the mean of the average pain score during the cycle. | Through the Cycle 1, Cycle 2, Cycle 3, Cycle 6 and Cycle 9 (each cycle is 25-35 days) | |
Secondary | The change from baseline in the number of days with a NRS score of 5 or over on the worst breast pain. | Participants will fill in the Cardiff Breast Pain Chart to assess the intensity of worst and average pain daily in the form of NRS score ranging from 0-10. 0 refers to no pain and 10 refers to the worst pain imaginable. The highest NRS score on the worst breast pain during the cycle is defined as the final score on the worst pain. | Through the Cycle 1, Cycle 2, Cycle 3, Cycle 6 and Cycle 9 (each cycle is 25-35 days) | |
Secondary | The change from baseline in the number of days with breast pain. | Participants will fill in the Cardiff Breast Pain Chart to assess the intensity of worst and average pain daily in the form of NRS score ranging from 0-10. 0 refers to no pain and 10 refers to the worst pain imaginable. | Through the Cycle 1, Cycle 2, Cycle 3, Cycle 6 and Cycle 9 (each cycle is 25-35 days) | |
Secondary | The proportion of patients reported "very much improved" or "much improved" per the Patient Global Impression of Change (PGIC). | PGIC is a 7-point scale reflecting patient's self-rating of overall improvement: "very much improved", "much improved", "minimally improved", "no change", "minimally worse", "much worse" or "very much worse". | At the end of the Cycle 3, Cycle 6 and Cycle 9 (each cycle is 25-35 days) | |
Secondary | The impact of breast pain on sexual life, daily life, mood and sleep rated by NRS scale. | NRS ranges from 0 to 10, with 0 indicating no impact and 10 indicating influence completely, and higher scores represent severer impact. | At the end of the Cycle 1, Cycle 2, Cycle 3, Cycle 6 and Cycle 9 (each cycle is 25-35 days) | |
Secondary | The change from baseline in the Sort Form 12-item Health Survey (SF-12). | The SF-12 is a general health questionnaire consisting of 12 questions. It investigates the patient's state of health via 8 different dimensions of general health perception, physical health, limited physical role function, physical pain, vitality, mental health, limited emotional role function, and social functioning. The sores of SF-12 range from 0 to 100, with higher scores indicating better physical and mental health functioning. | At the end of the Cycle 1, Cycle 2, Cycle 3, Cycle 6 and Cycle 9 (each cycle is 25-35 days) | |
Secondary | The change from baseline in the total and sub scores of Hospital Anxiety and Depression Scale (HADS). | HADS consists of 14 items, which are divided into two 7-item subscales to reflect a state of generalized anxiety and the depression. The respondent rates each item on a 4-point scale ranging from 0 (absence) to 3 (extreme presence). The total scores of HADS ranges from 0 to 42, with higher scores indicating severer symptoms. | At the end of the Cycle 1, Cycle 2, Cycle 3, Cycle 6 and Cycle 9 (each cycle is 25-35 days) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03391986 -
Acupuncture for Pain Management During Uterine Aspiration
|
N/A | |
Recruiting |
NCT05528263 -
Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)
|
N/A | |
Active, not recruiting |
NCT06070090 -
Tapping in Together: A Pilot Study on Group Acupuncture for Ketamine Experience Integration
|
N/A | |
Completed |
NCT03627533 -
The Differences of Oocyte Maturation, Granulosa Cell Apoptosis Index Between Electroacupuncture And Sham Groups IVF
|
N/A | |
Not yet recruiting |
NCT05794633 -
Acupuncture Therapy in Patients With Subacromial Impingement Syndrome
|
N/A | |
Recruiting |
NCT06001112 -
Immediate Analgesic Effects of Cheek Acupuncture for Acute Gouty Arthritis
|
N/A | |
Completed |
NCT04844710 -
The Effects of Acupuncture in Overcoming Inflammatory Response to COVID-19 Mild-moderate Symptoms
|
N/A | |
Active, not recruiting |
NCT04048941 -
One Needle Hand Acupuncture for MSK Disorders
|
N/A | |
Completed |
NCT04759079 -
The Effects of Acupuncture Against Postoperative Nausea and Vomit After Laparoscopic Cholecystectomy
|
N/A | |
Completed |
NCT03299439 -
Acupuncture Treatment for Knee Osteoarthritis With Sensitive Acupoints and Tender Points
|
N/A | |
Not yet recruiting |
NCT05537155 -
Buccal Acupuncture for Delirium Treatment in Older Patients Recovering From Orthopedic Surgery
|
N/A | |
Completed |
NCT03008668 -
A Pilot Trial of Acupuncture for Knee Osteoarthritis With Differential Functional Status of Acupoints
|
N/A | |
Completed |
NCT01283477 -
Efficacy of Acupuncture for Prophylaxis of Intrathecal Morphine Induced Pruritis in Patients Undergoing Caesarean Delivery
|
N/A | |
Recruiting |
NCT06042465 -
Investigation on Efficacy Between TCM Treatment Using Acupuncture and Tui-na With Physiotherapy on Patellofemoral Pain Syndrome
|
N/A | |
Recruiting |
NCT05516862 -
Determining the Right Acupuncture for Good Recovery Over Neuropsychiatric Trauma
|
N/A | |
Completed |
NCT03633097 -
Efficacy and Safety of Acupuncture Treatment as an Adjunctive Therapy After Knee Replacement
|
N/A | |
Active, not recruiting |
NCT05938660 -
Effects of Acupressure at Sanyinjiao Point on Primary Dysmenorrhea Among University Students.
|
N/A | |
Not yet recruiting |
NCT02597530 -
Different Stimuli of Transcutaneous Electric Acupoint Stimulation(TEAS) on Acupuncture Anesthesia
|
N/A | |
Recruiting |
NCT04249921 -
Evaluation of Acupuncture Effects for Complications After Surgery of Cerebellopontine Angle Tumor in Skull Base
|
||
Recruiting |
NCT05521737 -
Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy
|
N/A |